Target intelligence / Profile preview

Autoreactive T Cell Receptor (Autoreactive TCR)

Target
Autoreactive TCR
Molecular classification
Receptor, T Cell Receptor
01

Overview

An autoreactive T cell receptor (TCR) is a type of T cell receptor that recognizes self-antigens, potentially leading to autoimmune responses. While normally suppressed by tolerance mechanisms, their activation can contribute to diseases like type 1 diabetes, lupus, and multiple sclerosis. They are targets for therapeutic interventions aimed at restoring immune tolerance or eliminating pathogenic clones.

Other names
Self-reactive T Cell ReceptorAutoantigen-specific TCR
02

Mechanism of action

Varies depending on therapeutic strategy: includes blocking TCR signaling, depleting autoreactive T cells, or inducing tolerance.

03

Biological functions

Antigen recognitionImmune responseT cell activationCytokine productionCytotoxicity
04

Disease associations

Autoimmune diseasesType 1 diabetesLupus erythematosusMultiple sclerosisInflammation
05

Safety considerations

Off-target effects leading to immunosuppressionRisk of infectionIncreased cancer riskCytokine release syndrome (CRS) with TCR-targeted therapiesInduction of other autoimmune conditions.
06

Interacting drugs

Immunosuppressants

2 more in the full profile.

07

Biomarkers

Presence of autoreactive TCR clones in peripheral bloodTCR clonotype diversityCytokine profiles (e.g., IFN-γ, IL-17)Expression of activation markers (e.g., CD69, CD25)

Beyond the preview

Go deeper on Autoreactive T Cell Receptor (Autoreactive TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autoreactive T Cell Receptor (Autoreactive TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call